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Emil C. Gotschlich and Vincent A. Fischetti
 
On January 2, 2005, the scientific community lost a valued colleague and friend. 
Maclyn McCarty, or “Mac,” as he was better known, was perhaps most recognized 
for his part in the discovery of DNA as the carrier of genetic information. But
McCarty’s scientific career was long and fruitful, and his contributions to science 
were vast. This retrospective offers a look at some of Mac’s other notable scientific 
achievements.
 
Maclyn McCarty was born in the Mid-
west in 1911, the second of four sons
of a very close-knit and supportive fam-
ily. His interest in investigative medi-
cine arose in his early teens and led him
to study Medicine at Johns Hopkins
University, then the preeminent medi-
cal school. But first were his college
days at Stanford, where he had the
great fortune to study with Murray
Luck, a pioneer in biochemistry, with
whom Mac performed research on
liver proteins. In 1933, he was admit-
ted to Johns Hopkins, and there in ad-
dition to his medical curriculum he
further enriched his biochemical back-
ground, working with Leslie Heller-
man on a project in which he purified
heparin from 20-pound batches of beef
liver. This semiindustrial scale of bio-
chemical work prepared him well for
dealing with mass cultures of pneu-
mococci and later streptococci. Mac
trained for three years in Pediatrics at
Harriet Lane at Johns Hopkins. He
chose pediatrics in part because of the
dawning of a new age in infectious dis-
eases heralded in 1935 by the introduc-
tion of sulfonamide chemotherapy. In
1941, after a year at New York Uni-
versity, Mac arrived to work with Os-
wald Avery in the Rockefeller Hospital
and soon applied his strong biochemi-
cal skills to bring to its stunning con-
clusion the program of identifying the
chemical nature of the transforming
principle. On February 1, 1944, there
appeared in the 
 
Journal of Experimental
Medicine
 
 the paper authored by Avery,
Macleod, and McCarty entitled “Stud-
ies on the chemical nature of the
substance inducing transformation of
pneumococcal types” (1). It was the
first of a series of three papers that to-
gether provided decisive evidence that
DNA is the carrier of genetic informa-
tion. This feat furnished heredity with
a chemical basis, and thereby not only
opened a new era in biology, but
has fundamentally affected Western
thought and culture. The 
 
JEM 
 
at the
time of the 35th and 50th anniversaries
of this groundbreaking finding pub-
lished retrospectives recognizing and
celebrating this achievement.
Mac was a physician-scientist of
great distinction, and here we will
highlight his other contributions to the
biomedical sciences. A complete bibli-
ography of Mac’s work is provided at
the end of the online version of this ar-
ticle. In 1946, the offer to leave the
Avery laboratory and assume the lead-
ership of another Rockefeller labora-
tory working on streptococci and rheu-
matic fever provided the opportunity to
return to clinical disease-oriented re-
search. For Mac the mystery of a child
suffering with acute rheumatic fever as
a result of a prior streptococcal throat
infection was an irresistible challenge.
Over a period of several decades he
led ground-breaking work that estab-
lished the cell architecture of the Strep-
tococcus and the nature and location of
its important antigens. These studies
were paralleled by a clinical inquiry
of patients with rheumatic fever who
were admitted to the hospital, and led
to major advances in understanding the
immune responses in this disease. No-
table among these were his chemical
and clinical studies of the serum protein
C-reactive protein.
 
C-reactive protein
 
The work on C-reactive protein (CRP)
was a direct outgrowth of his ex-
perience in the Avery laboratory.
The protein had been discovered there
in 1930 and over the years had become
one of Avery’s “Red Seal Records”—
carefully rehearsed discourses by which
he shared his thoughts on a scientific
problem with colleagues and students
(2). The pneumococcal transformation
system required the addition of some
components that were most readily ob-
tained from human pathological pleural
or abdominal fluids. It was known
from the prior work in Avery’s labora-
tory that CRP protein was an acute
phase reactant, that its precipitation
with C-polysaccharide of the pneumo-
coccus (CPS) was calcium dependent,
and that CRP was found in the albu-
min fraction of serum upon ammo-
nium or sodium sulfate precipitation.
The prior method for purification of
CRP consisted of dialyzing the albu-
min fraction of serum against tap water
or distilled water containing traces of
calcium ion, which resulted in the pre-
cipitation of CRP. This property de-
pended on the presence of some lipid.
If the serum had been treated with al-
cohol or ether, this precipitation would
not occur. Mac had available large vol-
umes of two pathological fluids that
had proved unable to support the trans-
formation reaction. They were, how-
ever, very rich in CRP, and hence Mac
decided to purify the protein. Once he
had obtained the albumin fraction
by ammonium sulfate precipitation, he
noted that the protein did not come
out of solution with calcium at low
ionic strength. Therefore, he decided
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to use precipitation with CPS as a
method for purification. The CRP–
CPS precipitate was dissolved with ci-
trate containing saline. When sodium
sulfate was added, an amorphous pre-
cipitate developed which, over the
course of a few days, turned into nee-
dle-like crystals. These were harvested
by centrifugation, and the crystalliza-
tion was repeated. With this material
he obtained beautiful rhomboid plates
after a few days. Subsequent recrystalli-
zation occurred much more rapidly.
Chemical analysis of the purified CRP
indicated that it contained 14.66% ni-
trogen and no detectable phosphorus.
Since the CPS polysaccharide con-
tained 5.21% phosphorus, it meant that
the separation between the protein and
the polysaccharide had been accom-
plished effectively. The purified pro-
tein was used to immunize rabbits to
obtain antiserum that was able to detect
the purified C-reactive protein at very
low concentrations. The antiserum was
also tested against an acute and conva-
lescent serum from a patient with
type 14 pneumococcal pneumonia and
found to react only with the acute
phase serum (3).
However, fluids obtained subse-
quently were rich in lipids and proved
unsuitable for the previously described
purification method. In collaboration
with Harrison Wood and Robert
Slater, a modification of the procedure
was developed. This consisted of a very
gentle extraction of the interfering lip-
ids from the purified albumin fraction
with chloroform. After this extraction,
purification by precipitation with CPS
and crystallization induced by sodium
sulfate was performed readily as de-
scribed before. The purified protein
was characterized by free electrophore-
sis, and its isoelectric point was deter-
mined to be pH 4.82. Zone electro-
phoresis on starch-supported medium
indicated that the protein behaved as a
fast gamma globulin. Ultracentrifuga-
tion analysis indicated that the protein
moved as a single sharp peak with a
sedimentation constant at 7.5 (4).
The rabbit antiserum to crystalline
CRP proved a much more sensitive
way to detect the presence of CRP
than precipitation with CPS. The CRP
levels were determined by a new cap-
illary precipitation method with the
highly specific rabbit antiserum. Fur-
thermore, it had the distinct advantage
that there was no ambiguity with this
test since normal sera gave a negative
result. Mac, together with Wood, de-
cided to study this test on patients.
They reported a series of 45 patients
hospitalized for rheumatic fever at the
Rockefeller University Hospital, where
these patients remained until convales-
cence. The findings confirmed that this
test was more sensitive than the precip-
itation with CPS and that it was also
much easier to execute. CRP elevation
appeared to be the most reliable indica-
tor of rheumatic inflammatory activity
and responded more rapidly and reli-
ably than the Westergren sedimenta-
tion rate (5). In a subsequent study
with Slater that looked carefully at the
sera of patients with viral hepatitis, it
was found that only the antibody-
dependent test, and not the CPS pre-
cipitation test, was sensitive enough to
detect the presence of CRP. These
studies led a New York company,
Schieffelin and Co., to produce the an-
tiserum commercially, and initiated the
more widespread use of the CRP test
in American medicine (6).
Of course the question of the bio-
logical significance and function of CRP
had preoccupied Avery and continued
to intrigue Mac. This prompted him,
together with Harold Anderson, to fol-
low up some as yet inconclusive evi-
dence that the rabbit might produce a
similar substance in response to injury. It
was known that acute phase rabbit sera
did not react with CPS, and therefore,
they tested the possibility that some
other polysaccharide might be reactive.
They tested 10 type-specific or somatic
polysaccharides derived from 
 
Klebsiella
 
or pneumococci, and found that a
pneumococcal CPS preparation that had
been isolated and purified by a more
rapid method was able to precipitate a
protein from acute phase rabbit serum.
Using this polysaccharide, the purifica-
tion method using delipidated serum
successfully yielded crystalline protein.
They produced antisera in roosters and
with these demonstrated that the time
course of the appearance and disappear-
ance of rabbit CRP was analogous to
that seen in human beings (7).
In 1982, as the introductory speaker
at a New York Academy of Sciences
Symposium, Mac provided a very per-
sonal and comprehensive retelling of the
whole story of the discovery of CRP in
Avery’s laboratory and the thought pro-
cesses that led the early research of the
biological response (8). Today we know
that this protein is evolutionarily very
old. In many species, CRP is an acute
phase reactant; in others (such as mouse),
it is not responsive to injury; and in the
Syrian hamster, CRP production is an
estrogen-controlled response. Although
many functions have been attributed to
it, none is as yet totally compelling. Fur-
ther, there has been a renaissance of in-
terest in CRP as a possible marker for
coronary artery disease.
 
Physician-scientist
 
Mac immersed himself in the study of
patients with rheumatic fever on the
McCarty, 1942. Photo provided by the Rockefeller 
University Archive.
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wards of the Rockefeller Hospital. He
also took advantage of a remarkable
collection of clinical histories, strepto-
coccal isolates, serial throat cultures,
and bleedings that were obtained at the
Great Lakes Naval Training Center
during WWII. In collaboration with
Harold Anderson and Henry Kunkel,
he performed a very detailed study of
the immune response of recruits who
were admitted for scarlet fever and
were then followed for six weeks with
weekly throat cultures and bleedings.
At that time the quantitative test to
measure antibodies to streptokinase, a
streptococcal-secreted protein, had only
recently been developed and there was
limited information on the human anti-
body responses to this enzyme. Thus,
the primary aim of this study was to de-
termine whether the level of the anti-
streptokinase antibody responses was
correlated with the likelihood of devel-
oping rheumatic fever. These measure-
ments were compared with gamma
globulin levels and rises in antistrepto-
lysin O (ASO) titer. The results showed
that ASO, antistreptokinase titers, and
gamma globulin levels were clearly
higher in the group that went on to de-
velop rheumatic fever. The next high-
est average ASO and streptokinase any-
body titer (but not accompanied by
increased gamma globulin levels) was
seen in the group that had more than
one type of group A Streptococcus iso-
lated within the first two weeks of ob-
servation. The group with the lowest
ASO and antistreptokinase titers was
the group treated with penicillin with
no subsequent isolation of group A
streptococci. The authors emphasized
that not all patients who developed
rheumatic fever had higher titers of an-
tistreptococcal antibodies than patients
with uncomplicated streptococcal dis-
ease, but rather that the mean maxi-
mum titer of the rheumatic fever group
was consistently higher than that of the
patients who suffered no delayed com-
plications. The authors concluded that
the patients who went on to develop
rheumatic fever had a general propen-
sity to develop strong antibody responses
to antigens (9). Rockefeller University, 1937. Photo provided by the Rockefeller University Archive.
 
DNase and the immune response to 
streptococcal products
 
At the same time that Mac was con-
ducting the patient studies, he began
analyzing the group A Streptococcus
by chemical means. By 1948, several
enzymatically active extracellular prod-
ucts produced by group A streptococci
had been identified and partially char-
acterized. Mac noted that the culture
supernatants of streptococcal cultures
had both DNase and RNase activity.
He demonstrated that all of the 16
strains that he tested produced both
activities and that the difference be-
tween strains was minor. The degree
of DNase activity was very high
compared with culture supernatant of
pneumococcus, 
 
Bacillus subtilis
 
, or 
 
Es-
cherichia coli
 
 (10).
Mac developed a method to purify
these enzymes and then asked whether
antibodies to the enzyme would inhibit
its activity. Indeed, he was able to show
that this was the case and that with
some human sera the inhibitory activity
was extraordinarily high, being still ev-
ident at a dilution of 1:20,000. Using
this test he studied the same set of 90
sera from recruits at the Great Lakes
Naval base that had presented with
scarlet fever. He found that in contrast
with ASO or antistreptokinase anti-
bodies, which the majority of recruits
developed, only 38% showed a signifi-
cant anti-DNase activity. However,
some of those that responded had very
high titers. The average anti-DNase re-
sponse was again higher in the patients
who developed rheumatic fever (11).
Mac took note of the fact that fewer
recruits responded to this antigen than
to the other products studied. This ob-
servation led Lew Wannamaker, while
he was still in Mac’s laboratory, to
characterize streptococcal DNase and
discover that there were three immu-
nologically distinct DNases (12).
From the studies showing that as a
group individuals that develop rheu-
matic fever had a more exuberant im-
mune response to several streptococcal
antigens than those that did not de-
velop rheumatic fever, the question
arose whether these individuals were
generally immunologically hyperactive
or only hyperactive to streptococcal
antigens. Mac tested this, together with
William Kuhns, by determining the
immune response to diphtheria toxin
of normal volunteers compared with
patients that had recovered from rheu-
matic fever. The group consisted of
245 individuals ranging in from 9 to 26
years of age. 132 of these individuals
had a clear history of rheumatic fever.
By using the Schick test—the intrader-
mal injection of a minute quantity of
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diphtheria toxin that gives rise to a lo-
cal skin reaction unless antitoxic anti-
bodies are present—it was found that
there was no significant difference be-
tween the two groups in the percent-
age of subjects with preexisting neu-
tralizing antibodies to diphtheria toxin.
Furthermore, kinetics and level of anti-
bodies produced in response to immu-
nization with toxoid showed no dif-
ference between the groups. This is
perhaps the most incisive study, dem-
onstrating that the capacity to develop
rheumatic fever in response to strepto-
coccal infection cannot be attributed to
a generalized immunological hyperac-
tivity (13).
 
Attacking the streptococcal cell wall
 
Since very little was known about the
cellular structure of the group A Strep-
tococcus by the early 1950s, Mac be-
gan a series of systematic and elegant
experiments to understand the nature
of the cell wall and its relationship to
the observed serological response to
this organism. However, because the
Streptococcus is a gram-positive bacte-
rium with a very tough and highly re-
sistant cell wall, this endeavor proved
to be a challenge. Having a great deal
of experience with enzymes and how
to purify them, Mac elected to use
an enzymatic approach to disrupt the
bonds that hold the wall together.
Since enzyme supply companies such
as Sigma-Aldrich did not exist in those
days, one needed to go to the source to
isolate and purify the necessary en-
zymes. Using the soil organism 
 
Strepto-
myces albus
 
 as a source of cell wall–
degrading enzymes, Mac successfully
isolated a preparation from the growth
supernatant of these organisms that had
no proteolytic activity but could cause
streptococcal lysis (14).
He planned to use this new enzyme
preparation to disrupt the bonds that
maintained the integrity of the strepto-
coccal cell wall and thus release in solu-
tion the basic components of the wall.
However, to accomplish this he needed
to prepare isolated streptococcal cell
walls to avoid contaminating his digest
with cytoplasmic contents. Using a
thick-walled Pyrex flask and stainless
steel balls, he was able to grind a strepto-
coccal powder sufficiently to crush the
cells (14). Through a series of centrifu-
gation steps he successfully separated the
cell wall from the cytoplasmic contents.
The dry crushing process was later re-
placed by an oscillating machine that
shook a suspension of streptococci in
the presence of fine glass beads and ac-
complished the same task, but more effi-
ciently. Using this purified cell wall as a
substrate for the Streptomyces enzyme,
Mac isolated a soluble carbohydrate
fraction of the streptococcal cell wall
that was highly water soluble. Applying
some elegant chemistry to this solubi-
lized cell wall preparation, he deter-
mined that the streptococcal cell wall
consisted of about one third protein and
two thirds carbohydrate, with the car-
bohydrate portion composed primarily
of 
 
N
 
-acetyl-glucosamine and rham-
nose. More importantly, he found that
the serological reactivity of the soluble
carbohydrate when tested with group A
antistreptococcal antisera was compara-
ble to the material isolated from strepto-
cocci by the Lancefield acid extraction
technique and thus represents the
group-specific antigen for streptococci.
At the time, variant group A strepto-
cocci were available that did not react
with the conventional group A typing
antisera, so Mac explored the basis of
this difference. Using the same tech-
niques applied to the group A strepto-
coccal cell walls, he discovered that the
variant carbohydrate was reduced in the
amount of total 
 
N
 
-acetyl-glucosamine.
To get a better handle on this differ-
ence, he isolated soil organisms by
growing them in the presence of the
group A or the variant polysaccharide as
the only carbon source and selecting for
the ability to degrade the serological re-
activity of the antigens. Thus, he was
able to isolate and purify enzymes that
were able to destroy the serological ac-
tivity of group A–specific and variant-
specific antisera. He found that the vari-
ant-specific enzyme released rhamnose
from the variant carbohydrate, whereas
the group A–specific enzyme released
 
N
 
-acetyl-glucosamine. Furthermore, he
found that treatment of the group A
carbohydrate with the latter enzyme ab-
rogated its reactivity with group A anti-
serum but made it reactive with the
variant antiserum. His interpretation of
these results was that the group A carbo-
hydrate was composed of an undeter-
mined number of rhamnose side chains
with a terminal 
 
N
 
-acetyl-glucosamine
and that the variant carbohydrate lacked
the terminal 
 
N
 
-acetyl-glucosamine (14).
The linkage to the rhamnose could be
either 
 
 
 
 or 
 
 
 
; however, this could not
be resolved at that time. Six years later,
using the azo antigen technique, in
which 
 
p
 
-aminophenyl-
 
 
 
-
 
N
 
-acetyl-glu-
cosamine could be linked to egg albu-
min, he showed that this complex and
not the 
 
 
 
 form was reactive with the
group A antisera (15). He went on to
show that the phenyl-
 
 
 
-
 
N
 
-acetyl-glu-
cosamine and not the 
 
 
 
 form could in-
duce the cleaving enzyme from the soil
organism. From this he concluded
that 
 
 
 
-
 
N
 
-acetyl-glucosamine side chains
represent the major antigenic determi-
nant of group A streptococci. Decades
later, his structural interpretation was
proven to be entirely correct based on
the NMR structure of these carbohy-
drates (16, 17).
In collaboration with Richard
Krause in Mac’s lab, the same chemical
and enzymatic experiments were per-
formed with group C streptococci,
which revealed a similar composition
Rockefeller Hospital, 1946. Photo provided by 
the Rockefeller University Archive.
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of the cell wall polysaccharide to that
found in the group A organisms. (18)
However, in the group C polysac-
charide, 
 
N
 
-acetyl-galactosamine rather
than 
 
N
 
-acetyl-glucosamine predomi-
nated and was the basis of the serologi-
cal specificity of the group C organism.
In a related paper, Krause and McCarty
identified group C streptococcal mu-
tants that reacted with antiserum di-
rected to the group A variant strepto-
cocci (19). Using the enzymes from
the soil organism in experiments per-
formed for the group A and A variant
streptococci, the authors concluded
that these group C mutants were simi-
lar to the A variant streptococci in that
their polysaccharide was composed of
rhamnose and lacked the terminal
 
N
 
-acetyl-galactosamine (18).
During the course of his serological
studies, Mac found that extracts of sev-
eral streptococcal groups and other
gram-positive bacteria reacted with an-
tisera directed to certain streptococci,
indicating that the reactive substance
was widely distributed in bacteria (20).
Using these cross-reactive antisera as a
reagent to follow the substance, he pu-
rified this common component to ho-
mogeneity from streptococcal extracts.
Through qualitative and elemental
chemical analysis he found that antigen
was a simple polymer of glycerophos-
phate. This purified material reacted
serologically with antiserum and was
identical by infrared spectra with syn-
thetic polyglycerophosphate. He fur-
ther found that only certain gram-posi-
tive and not gram-negative bacteria
contained this polymer. It was later dis-
covered by James Baddiley (21) that
the polyglycerolposphate belonged to a
class of glycerol teichoic acids which
contained ester-linked D-alanine. Based
on this finding Mac went on to prove
that the major antigenic determinant
for the Ala-polyglycerophosphate was
in fact the linked alanine (22).
McCarty and his colleagues pro-
ceeded to dig deeper into the cell wall
of the Streptococcus to understand
more of its basic components. In col-
laboration with Krause, they chemi-
cally extracted the group carbohydrate
with hot formamide from both group
A and A variant streptococci and found
that this extract contained the expected
carbohydrates for their respective
groups. They also discovered that the
residue of this chemical extraction was
composed of 
 
N
 
-acetyl-muramic acid,
 
N
 
-acetyl-glucosamine, and the amino
acids alanine, glutamic acid, lysine, and
glycine and represented the mucopep-
tide (later called peptidoglycan) of the
cell wall. Since this residue was at-
tacked by the phage lysin, the 
 
Strepto-
myces albus
 
 enzyme, and lysozyme, they
concluded that the linkages split by
these enzymes were found in the mu-
copeptide fraction of the cell wall and
not the group carbohydrate.
 
Opaque versus blue colonies
 
In 1966, Mac attempted to explain a
long standing phenomenon of group
A streptococci grown on agar plates.
Colony forms appeared which, when
viewed under indirect lighting, ap-
peared opaque in comparison to the
blue appearance of the majority of the
streptococci on the plate. Although
there were several theories as to the rea-
son for this opaque appearance, nothing
definitive was known. To approach the
problem, Mac ruled out the presence of
new surface structures or molecules that
were over- or underexpressed based on
both serological and chemical analysis
of the opaque and blue bacterial forms
(23). As it is often in science, the an-
swer usually reveals itself unexpectedly.
During a routine examination of the
opaque colony forms under the micro-
scope, he found that the streptococci
were in extremely long chains (hun-
dreds of cocci per chain) compared
with the short chains (
 
 
 
10 cocci per
chain) produced by the blue colony
forms. Further detailed experiments
prompted by this observation revealed
that the stability of these chains was not
the result of the relatively weak interac-
tion of proteins or surface carbohydrate
but was likely due to the lack of separa-
tion of the peptidoglycans during cell
division (23). Subsequently, in an ele-
gant electron microscopy study of these
unusual streptococci with John Swan-
son (24), it was clear that his conclu-
sions were correct.
 
Mac’s thoughts on rheumatic fever
 
Because of the scientific prominence of
Mac’s studies of streptococcal biology
and his interest in the clinical aspects
of rheumatic fever over the years, he
was repeatedly asked to summarize his
thoughts about this problem. Thus, by
reading the reviews that he wrote over a
period of two decades, one can see the
evolution of his thoughts. In 1951, in a
presentation at a meeting at the New
York Academy of Medicine (25), Mac
takes it as a given that preceding strep-
tococcal infection is seen very com-
monly in rheumatic fever: “Whether
the disease can be initiated by any other
event cannot be excluded, remains a
very difficult question, but is not sup-
ported by any evidence. To further
complicate the issue are the recurrences
and recrudescence of rheumatic fever.”
He proceeds to review the main hy-
potheses for the causation of the disease
existing at that moment in time. He
mentions the deleterious effects of strep-
tolysin O on membranes of isolated frog
heart cells and that this may be a prom-
ising line to pursue. He makes mention
of hyaluronidase as a potential agent of
disease because it affects the extracellular
matrix that is the location of the strepto-
coccal infection. Furthermore, although
streptococci grown in vitro often do not
produce hyaluronidase, Mac reasoned
that it must be produced in vivo during
infection because antihyaluronidase an-
tibodies are at least as common as ASO
antibodies after infection. He takes note
of the fact that rheumatic fever has been
classified by many as a collagen disease.
He suggests that this is a misleading
name, and notes that the fibrinoid found
in Aschoff bodies or subcutaneous nod-
ules is not collagen, but rather degrading
myofibers. His own view was that im-
mune causation is the most probable ex-
planation for disease. Favoring this hy-
pothesis is that an immune response to
streptococcal antigens is almost invari-
ably seen, the latent period of about
three weeks is in keeping with the ki-
netics of an immune response, patients
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with rheumatic fever have a more pro-
nounced immune response, and finally
that effective treatment of the infection
with penicillin prevents the onset of
rheumatic fever. In this review, Mac
recognizes that the chronic nature of the
inflammatory disease presents a chal-
lenging problem. However, he suggests
that it is possible that certain streptococ-
cal products have physical and chemical
properties that could account for the
long persistence in human tissues. Al-
though he does not state it explicitly in
this review, it is likely Mac was already
thinking of the cell wall. Speaking of
the treatment of the disease, he takes
note that although ACTH, cortisol, or
salicylates are certainly helpful in con-
trolling the acute inflammatory aspects
of the disease, there is actually no data
whether they prevent the chronic val-
vular disease (25).
In 1956, Mac again discussed in de-
tail the various hypotheses for the etiol-
ogy of rheumatic fever (26). Although
recognizing the complexity of the
problem, he notes that rheumatic fever,
as a disease, is more amenable to study
than the other so-called collagen dis-
eases where no underlying cause was
known at the time and, for the most
part, remains unknown today. He dis-
cusses the possibility that live strepto-
cocci are involved in this disease. Mac,
although he did not subscribe to this
hypothesis, felt that it could not be de-
finitively excluded with the data avail-
able at that point in time. Again, his
own thinking leaned toward an immu-
nological hypersensitivity reaction. He
notes that it is quite clear that on aver-
age the immune response to strepto-
coccal antigens is higher in the group
that proceeds to development of rheu-
matic fever. However, on an individual
basis the level of the immune response
obtained does not have predictive value.
This raises the question of whether this
population exhibits a general hyper-
reactivity to antigenic stimulation. Mac
points out that the study of the immu-
nogenicity of unrelated antigens, and in
particular to diphtheria toxoid in nor-
mal controls and in individuals who
have had rheumatic fever, indicates
clearly that the there is no generalized
hyperreactivity. Since it is the response
to streptococcal products in general
that is aberrant, the difficulty becomes
to identify a particular streptococcal
product in the etiology of rheumatic
fever. At this point, Mac’s interest was
aroused by the streptococcal cell wall,
based on the fact that no known mech-
anism operative in human tissues had
been identified that was capable of de-
grading this highly resistant structure.
In this 1956 review, he does not over-
look the fact that there must be some
genetic basis for the susceptibility to
this disease because only a subset of
those infected with streptococci de-
velop the disease (26).
In a 1964 review, he tries to come
to grips with what might be the unique
properties of group A Streptococcus
that is involved in rheumatic fever (27).
Mac points out that this really is an ab-
breviation of the more complex ques-
tion: “On the assumption that rheu-
matic fever results from the tissue
response of a susceptible human being
to some constituent of the Streptococ-
cus, what components of the host re-
sponse and what constituents on the
microorganism are involved, and how
do they interact to produce the dis-
ease?” This question had led to broad
efforts directed toward a detailed analy-
sis of the group A Streptococcus, and
these studies had yielded a very rich
body of knowledge about this species.
Mac notes the intriguing possibility
that cell wall–less L-forms that are to-
tally resistant to penicillin are a theoret-
ical possibility for the pathogenesis of
this disease. The richness of antigens to
consider and the diversity of unex-
plained aspects of the disease make the
identification of the pathogenesis ex-
tremely daunting. He illustrates this
complexity by following the fate of
one of his own favorite hypotheses: the
role of the group A cell wall carbohy-
drate. This substance is an attractive
candidate because it is the defining an-
tigen of group A Streptococcus. It is an
insoluble portion of the cell wall, a
structure that is difficult to digest by
human degradative processes. Its anti-
genic signature is terminal 
 
N
 
-acetyl
glucosamine residues. This sugar cer-
tainly occurs in many human tissues
and may be exposed in the terminal
position either during biosynthesis or
degradation. However, he notes that
tests of this hypothesis indicated that
Colin MacCleod, Maclyn McCarty, and Detlev Bronk, 1965. Photo provided by the Rockefeller Univer-
sity Archive.
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the human immune response to group
A polysaccharide was not dramatic or
consistently produced. Furthermore,
numerous attempts to identify a human
tissue component where the 
 
N
 
-acetyl
glucosamine is situated in a linkage that
provides a cross-reactive antigen were
unsuccessful. Nevertheless, Mac ex-
presses his confidence that further char-
acterization of the basic biology of the
Streptococcus is ultimately necessary
for the solution of the problem (27).
In a 1972 review, he notes that his
views on the problem of the pathogene-
sis of rheumatic fever had changed little
over the years and that this was due to
the fact that there had not been any
substantive changes in the information
available (28). At this time, one school
of thought focused on the possibility
that the toxic molecules of the Strepto-
coccus were involved. For instance, the
disease could be due to a toxic manifes-
tation in response to the nonimmuno-
genic streptolysin S, which was known
to have the ability to attack a wide vari-
ety of cell membranes. Mac comments
that the lack of an immune response
could explain the recurrent nature of
the disease. The streptolysin O is also a
potent toxin, which had been shown to
have deleterious effects on cardiac myo-
cytes in vitro (29). However, since anti-
bodies to it are almost always engen-
dered, many workers had found it
difficult to accept a causative role be-
cause of the well-known propensity for
the disease to recur in the absence of
penicillin prophylaxis. Some held that
the immune response causes the toxin
to circulate in the form of immune
complexes that will lodge in tissues.
This view suggests that the slow degra-
dation of the complexes might release
the toxin and cause damage. This vari-
ant hypothesis would explain the latent
nature of the disease, and the immune
response would actually be a contribut-
ing factor (28, 29).
A hypothesis that bridges direct
toxicity and immune responses was put
forth by Schwab and Cromartie who
demonstrated that cell wall fragments
obtained by sonication, when injected
subcutaneously into rabbits, produced
McCarty, 1982. Photo provided by the Rockefeller University Archive.
 
a nodular and relapsing skin lesion.
When injected intraperitoneally, focal
lesions were seen in the heart and other
organs (30, 31). The activity was de-
pendent on the particulate nature of
the material and was probably a re-
sponse to the peptidoglycan. With the
recognition in the last dozen years of
Toll-like receptors and their capacity to
recognize microbial components, such
as peptidoglycan, and stimulate im-
mune responses, revisiting this model
might be very instructive.
The other theories for the causation
of this disease at that time relied on
concepts of autoimmunity. Mac was
particularly impressed by the remark-
able number of instances of molecular
mimicry of human antigens by the
Streptococcus, a concept developed in
great part by John Zabriskie while
working in Mac’s lab. The hyaluronic
capsule of streptococci is chemically
identical to the hyaluronic acid in the
extracellular matrix. Indeed, immu-
nological cross-reactions of group A
polysaccharide and heart valve glyco-
protein have been described. M protein
and streptococcal cell membrane com-
ponents have strong cross-reactions
with the sarcolemma of cardiac muscle.
Heart-reactive antibody levels rise in
patients with rheumatic fever and di-
minish during convalescence. Particu-
larly striking is the fact that they rise
again with rheumatic recurrences (32).
Cross-reactions with histocompatibil-
ity antigens have also been described.
Mac emphasized that the absence of an
animal model makes it extraordinarily
difficult to verify or reject any of the
various theories of pathogenesis (33).
Finally, in reviewing the immuno-
logical basis of rheumatic fever in 1980
Mac finds several aspects that render
the evidence for molecular mimicry by
Streptococcus very strong. In addition
to the arguments presented previously,
he cites the then recent finding that pa-
tients with chorea have antibodies re-
active with subthalamic and caudate
nuclei of the brain (34). Over the years
it had become evident that the patients
with rheumatic fever produce an im-
mune response to over a dozen se-
creted proteins, to cell wall polysaccha-
rides, and to several antigens of the
streptococcal cell membrane. Both hu-
moral and cellular responses had been
documented. But it had not been pos-
sible to inculpate the immune response
to any particular antigen as the patho-
genetic basis of the disease. Mac, how-
ever, felt that this multiplicity of im-
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mune responses to different antigens
might be the explanation for the diver-
sity of the clinical manifestations of the
disease. He was thinking of separate
immune mechanisms for the causation
of, for instance, valvulitis compared
with myocarditis (35).
Thus, as new data accumulated
from many laboratories over the years,
very often led by individuals that he
trained, there was a shift in Mac’s focus
and emphasis in his writings about
rheumatic fever. The earlier papers fo-
cused on justifying and cementing the
role of group A infection. They were
also very focused on enzymatically ac-
tive extracellular products and the im-
mune response to them. His own work
added one important new component
to this set, the DNase. As his work
on the cell wall anatomy and immu-
nochemistry matured, he took as a
given the streptococcal causation of dis-
ease, and moved to a view that began
to include aberrant immune reactions.
Very careful studies indicated that
quantitatively there is an unusually
strong immune response to streptococ-
cal antigens in patients with rheumatic
fever. However, the response of diph-
theria toxin, an unrelated antigen, was
not out of normal bounds. As the
immunochemical dissection proceeded
further, much of it by members of his
own lab or from a handful of investiga-
tors strongly influenced by his method-
ology, the findings emerged that there
are a surprising number of streptococcal
antigens that cross-react serologically
with human tissue antigens. His view of
the pathogenesis was eventually cogni-
zant of these mimetic relationships (36).
However, in this 1979 article
 
 
 
he recog-
nizes that the field is rich in interesting
and innovative theories for the causal
link between streptococcal infection
and the nonsupurative sequelae. But he
also points out that the field unfortu-
nately lacks any credible animal model
and hence is bereft of methodology to
verify any particular hypothesis.
This recounting of the achieve-
ments of Mac as a scientist only touches
upon the highlights of his scientific
contributions. His enormous impact as
a mentor, a model of professional in-
tegrity, and a statesman for science
should be the subject for another bio-
graphical retrospective. Mac was quint-
essentially a physician-scientist. Being a
member of the trio that established
DNA as the chemical basis of heredity
did not cause him to deviate from his
goal of applying his scientific prowess
to patient-oriented research. He lived a
long and very fruitful life, and medi-
cine and science have benefited from
his manifold contributions.
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